位置:首页 > 蛋白库 > PAT_ARATH
PAT_ARATH
ID   PAT_ARATH               Reviewed;         475 AA.
AC   Q9SIE1; E9L7A7; Q3E6N9; Q8LFX1; Q8VZI1;
DT   30-NOV-2010, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2002, sequence version 2.
DT   03-AUG-2022, entry version 146.
DE   RecName: Full=Bifunctional aspartate aminotransferase and glutamate/aspartate-prephenate aminotransferase;
DE            Short=AtAAT;
DE            Short=AtPPA-AT;
DE            EC=2.6.1.1;
DE            EC=2.6.1.78;
DE            EC=2.6.1.79;
DE   AltName: Full=Protein MATERNAL EFFECT EMBRYO ARREST 17;
DE   Flags: Precursor;
GN   Name=PAT; Synonyms=AAT, MEE17; OrderedLocusNames=At2g22250;
GN   ORFNames=T26C19.9;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliopsida; eudicotyledons; Gunneridae; Pentapetalae;
OC   rosids; malvids; Brassicales; Brassicaceae; Camelineae; Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=21102469; DOI=10.1038/nchembio.485;
RA   Maeda H., Yoo H., Dudareva N.;
RT   "Prephenate aminotransferase directs plant phenylalanine biosynthesis via
RT   arogenate.";
RL   Nat. Chem. Biol. 7:19-21(2011).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=10617197; DOI=10.1038/45471;
RA   Lin X., Kaul S., Rounsley S.D., Shea T.P., Benito M.-I., Town C.D.,
RA   Fujii C.Y., Mason T.M., Bowman C.L., Barnstead M.E., Feldblyum T.V.,
RA   Buell C.R., Ketchum K.A., Lee J.J., Ronning C.M., Koo H.L., Moffat K.S.,
RA   Cronin L.A., Shen M., Pai G., Van Aken S., Umayam L., Tallon L.J.,
RA   Gill J.E., Adams M.D., Carrera A.J., Creasy T.H., Goodman H.M.,
RA   Somerville C.R., Copenhaver G.P., Preuss D., Nierman W.C., White O.,
RA   Eisen J.A., Salzberg S.L., Fraser C.M., Venter J.C.;
RT   "Sequence and analysis of chromosome 2 of the plant Arabidopsis thaliana.";
RL   Nature 402:761-768(1999).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RX   PubMed=27862469; DOI=10.1111/tpj.13415;
RA   Cheng C.Y., Krishnakumar V., Chan A.P., Thibaud-Nissen F., Schobel S.,
RA   Town C.D.;
RT   "Araport11: a complete reannotation of the Arabidopsis thaliana reference
RT   genome.";
RL   Plant J. 89:789-804(2017).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=14593172; DOI=10.1126/science.1088305;
RA   Yamada K., Lim J., Dale J.M., Chen H., Shinn P., Palm C.J., Southwick A.M.,
RA   Wu H.C., Kim C.J., Nguyen M., Pham P.K., Cheuk R.F., Karlin-Newmann G.,
RA   Liu S.X., Lam B., Sakano H., Wu T., Yu G., Miranda M., Quach H.L.,
RA   Tripp M., Chang C.H., Lee J.M., Toriumi M.J., Chan M.M., Tang C.C.,
RA   Onodera C.S., Deng J.M., Akiyama K., Ansari Y., Arakawa T., Banh J.,
RA   Banno F., Bowser L., Brooks S.Y., Carninci P., Chao Q., Choy N., Enju A.,
RA   Goldsmith A.D., Gurjal M., Hansen N.F., Hayashizaki Y., Johnson-Hopson C.,
RA   Hsuan V.W., Iida K., Karnes M., Khan S., Koesema E., Ishida J., Jiang P.X.,
RA   Jones T., Kawai J., Kamiya A., Meyers C., Nakajima M., Narusaka M.,
RA   Seki M., Sakurai T., Satou M., Tamse R., Vaysberg M., Wallender E.K.,
RA   Wong C., Yamamura Y., Yuan S., Shinozaki K., Davis R.W., Theologis A.,
RA   Ecker J.R.;
RT   "Empirical analysis of transcriptional activity in the Arabidopsis
RT   genome.";
RL   Science 302:842-846(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Brover V.V., Troukhan M.E., Alexandrov N.A., Lu Y.-P., Flavell R.B.,
RA   Feldmann K.A.;
RT   "Full-length cDNA from Arabidopsis thaliana.";
RL   Submitted (MAR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   STRAIN=cv. Columbia;
RX   PubMed=14993207; DOI=10.1101/gr.1515604;
RA   Castelli V., Aury J.-M., Jaillon O., Wincker P., Clepet C., Menard M.,
RA   Cruaud C., Quetier F., Scarpelli C., Schaechter V., Temple G., Caboche M.,
RA   Weissenbach J., Salanoubat M.;
RT   "Whole genome sequence comparisons and 'full-length' cDNA sequences: a
RT   combined approach to evaluate and improve Arabidopsis genome annotation.";
RL   Genome Res. 14:406-413(2004).
RN   [7]
RP   FUNCTION.
RX   PubMed=15634699; DOI=10.1242/dev.01595;
RA   Pagnussat G.C., Yu H.-J., Ngo Q.A., Rajani S., Mayalagu S., Johnson C.S.,
RA   Capron A., Xie L.-F., Ye D., Sundaresan V.;
RT   "Genetic and molecular identification of genes required for female
RT   gametophyte development and function in Arabidopsis.";
RL   Development 132:603-614(2005).
RN   [8]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=16623902; DOI=10.1111/j.1365-313x.2006.02713.x;
RA   de la Torre F., De Santis L., Suarez M.F., Crespillo R., Canovas F.M.;
RT   "Identification and functional analysis of a prokaryotic-type aspartate
RT   aminotransferase: implications for plant amino acid metabolism.";
RL   Plant J. 46:414-425(2006).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY, FUNCTION, CATALYTIC ACTIVITY, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=20883697; DOI=10.1016/j.febslet.2010.09.037;
RA   Graindorge M., Giustini C., Jacomin A.C., Kraut A., Curien G., Matringe M.;
RT   "Identification of a plant gene encoding glutamate/aspartate-prephenate
RT   aminotransferase: The last homeless enzyme of aromatic amino acids
RT   biosynthesis.";
RL   FEBS Lett. 584:4357-4360(2010).
CC   -!- FUNCTION: Prokaryotic-type aspartate aminotransferase. Has also a
CC       prenate transaminase activity. Involved in the aromatic amino acids
CC       biosynthesis pathway via the arogenate route. Required for the
CC       transamination of prephenate into arogenate. Required for early
CC       development of the embryo. {ECO:0000269|PubMed:15634699,
CC       ECO:0000269|PubMed:16623902, ECO:0000269|PubMed:20883697}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-oxoglutarate + L-aspartate = L-glutamate + oxaloacetate;
CC         Xref=Rhea:RHEA:21824, ChEBI:CHEBI:16452, ChEBI:CHEBI:16810,
CC         ChEBI:CHEBI:29985, ChEBI:CHEBI:29991; EC=2.6.1.1;
CC         Evidence={ECO:0000269|PubMed:20883697};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-arogenate + oxaloacetate = L-aspartate + prephenate;
CC         Xref=Rhea:RHEA:20445, ChEBI:CHEBI:16452, ChEBI:CHEBI:29934,
CC         ChEBI:CHEBI:29991, ChEBI:CHEBI:58180; EC=2.6.1.78;
CC         Evidence={ECO:0000269|PubMed:20883697};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-oxoglutarate + L-arogenate = L-glutamate + prephenate;
CC         Xref=Rhea:RHEA:22880, ChEBI:CHEBI:16810, ChEBI:CHEBI:29934,
CC         ChEBI:CHEBI:29985, ChEBI:CHEBI:58180; EC=2.6.1.79;
CC         Evidence={ECO:0000269|PubMed:20883697};
CC   -!- COFACTOR:
CC       Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
CC         Evidence={ECO:0000250};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=12 mM for aspartate for the asparte aminotransferase activity
CC         {ECO:0000269|PubMed:20883697, ECO:0000269|PubMed:21102469};
CC         KM=5.6 mM for glutamate for the asparte aminotransferase activity
CC         {ECO:0000269|PubMed:20883697, ECO:0000269|PubMed:21102469};
CC         KM=25 uM for oxaloacetate for the asparte aminotransferase activity
CC         {ECO:0000269|PubMed:20883697, ECO:0000269|PubMed:21102469};
CC         KM=200 uM for 2-oxoglutarate for the asparte aminotransferase
CC         activity {ECO:0000269|PubMed:20883697, ECO:0000269|PubMed:21102469};
CC         KM=14 uM for prephenate for the prephenate aminotransferase activity
CC         {ECO:0000269|PubMed:20883697, ECO:0000269|PubMed:21102469};
CC         KM=1.5 mM for glutamate for the prephenate aminotransferase activity
CC         {ECO:0000269|PubMed:20883697, ECO:0000269|PubMed:21102469};
CC         KM=2.2 mM for aspartate for the prephenate aminotransferase activity
CC         {ECO:0000269|PubMed:20883697, ECO:0000269|PubMed:21102469};
CC         KM=355 uM for prephenate (for the recombinant enzyme with 20 mM
CC         aspartate as cosubstrate) {ECO:0000269|PubMed:20883697,
CC         ECO:0000269|PubMed:21102469};
CC         KM=684 uM for prephenate (for the recombinant enzyme with 20 mM
CC         glutamate as cosubstrate) {ECO:0000269|PubMed:20883697,
CC         ECO:0000269|PubMed:21102469};
CC         KM=691 uM for 2-oxoglutarate (for the recombinant enzyme with 20 mM
CC         aspartate as cosubstrate) {ECO:0000269|PubMed:20883697,
CC         ECO:0000269|PubMed:21102469};
CC         KM=2.69 mM for glutamate (for the recombinant enzyme with 3 mM
CC         prephenate as cosubstrate) {ECO:0000269|PubMed:20883697,
CC         ECO:0000269|PubMed:21102469};
CC         KM=2.84 mM for aspartate (for the recombinant enzyme with 3 mM
CC         prephenate as cosubstrate) {ECO:0000269|PubMed:20883697,
CC         ECO:0000269|PubMed:21102469};
CC         KM=8.22 mM for oxaloacetate (for the recombinant enzyme with 20 mM
CC         glutamate as cosubstrate) {ECO:0000269|PubMed:20883697,
CC         ECO:0000269|PubMed:21102469};
CC         Vmax=88 nmol/sec/mg enzyme toward prephenate with 20 mM aspartate as
CC         cosubstrate {ECO:0000269|PubMed:20883697,
CC         ECO:0000269|PubMed:21102469};
CC         Vmax=173 nmol/sec/mg enzyme toward prephenate with 20 mM glutamate as
CC         cosubstrate {ECO:0000269|PubMed:20883697,
CC         ECO:0000269|PubMed:21102469};
CC         Vmax=325 nmol/sec/mg enzyme toward 2-oxoglutarate with 20 mM
CC         aspartate as cosubstrate {ECO:0000269|PubMed:20883697,
CC         ECO:0000269|PubMed:21102469};
CC         Vmax=90 nmol/sec/mg enzyme toward glutamate with 3 mM prephenate as
CC         cosubstrate {ECO:0000269|PubMed:20883697,
CC         ECO:0000269|PubMed:21102469};
CC         Vmax=70 nmol/sec/mg enzyme toward aspartate with 3 mM prephenate as
CC         cosubstrate {ECO:0000269|PubMed:20883697,
CC         ECO:0000269|PubMed:21102469};
CC         Vmax=3.29 umol/sec/mg enzyme toward oxaloacetate with 20 mM glutamate
CC         as cosubstrate {ECO:0000269|PubMed:20883697,
CC         ECO:0000269|PubMed:21102469};
CC   -!- PATHWAY: Amino-acid biosynthesis; L-phenylalanine biosynthesis; L-
CC       arogenate from prephenate (L-Asp route): step 1/1.
CC   -!- PATHWAY: Amino-acid biosynthesis; L-phenylalanine biosynthesis; L-
CC       arogenate from prephenate (L-Glu route): step 1/1.
CC   -!- SUBUNIT: Homodimer. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Plastid, chloroplast
CC       {ECO:0000269|PubMed:16623902}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9SIE1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9SIE1-2; Sequence=VSP_040191;
CC   -!- SIMILARITY: Belongs to the class-I pyridoxal-phosphate-dependent
CC       aminotransferase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; HM638413; ADM67558.1; -; mRNA.
DR   EMBL; AC007168; AAD23617.2; -; Genomic_DNA.
DR   EMBL; CP002685; AEC07283.1; -; Genomic_DNA.
DR   EMBL; CP002685; AEC07284.1; -; Genomic_DNA.
DR   EMBL; CP002685; AEC07285.1; -; Genomic_DNA.
DR   EMBL; AY064152; AAL36058.1; -; mRNA.
DR   EMBL; AY124811; AAM70520.1; -; mRNA.
DR   EMBL; AY084599; AAM61164.1; -; mRNA.
DR   EMBL; BX820081; -; NOT_ANNOTATED_CDS; mRNA.
DR   PIR; E84610; E84610.
DR   RefSeq; NP_001031394.1; NM_001036317.1. [Q9SIE1-1]
DR   RefSeq; NP_565529.1; NM_127791.3. [Q9SIE1-1]
DR   RefSeq; NP_850022.1; NM_179691.4. [Q9SIE1-2]
DR   PDB; 5WMH; X-ray; 3.00 A; A/B/C/D/E/F=1-475.
DR   PDB; 5WMI; X-ray; 2.00 A; A=1-475.
DR   PDB; 5WMK; X-ray; 1.40 A; A=1-475.
DR   PDB; 5WML; X-ray; 2.10 A; A/B=1-475.
DR   PDB; 6F5V; X-ray; 1.70 A; A/B/C/D=1-475.
DR   PDBsum; 5WMH; -.
DR   PDBsum; 5WMI; -.
DR   PDBsum; 5WMK; -.
DR   PDBsum; 5WML; -.
DR   PDBsum; 6F5V; -.
DR   AlphaFoldDB; Q9SIE1; -.
DR   SMR; Q9SIE1; -.
DR   BioGRID; 2111; 2.
DR   STRING; 3702.AT2G22250.2; -.
DR   PaxDb; Q9SIE1; -.
DR   PRIDE; Q9SIE1; -.
DR   ProteomicsDB; 248639; -. [Q9SIE1-1]
DR   EnsemblPlants; AT2G22250.1; AT2G22250.1; AT2G22250. [Q9SIE1-2]
DR   EnsemblPlants; AT2G22250.2; AT2G22250.2; AT2G22250. [Q9SIE1-1]
DR   EnsemblPlants; AT2G22250.3; AT2G22250.3; AT2G22250. [Q9SIE1-1]
DR   GeneID; 816758; -.
DR   Gramene; AT2G22250.1; AT2G22250.1; AT2G22250. [Q9SIE1-2]
DR   Gramene; AT2G22250.2; AT2G22250.2; AT2G22250. [Q9SIE1-1]
DR   Gramene; AT2G22250.3; AT2G22250.3; AT2G22250. [Q9SIE1-1]
DR   KEGG; ath:AT2G22250; -.
DR   Araport; AT2G22250; -.
DR   TAIR; locus:2060435; AT2G22250.
DR   eggNOG; KOG0257; Eukaryota.
DR   InParanoid; Q9SIE1; -.
DR   OrthoDB; 683031at2759; -.
DR   PhylomeDB; Q9SIE1; -.
DR   BioCyc; ARA:AT2G22250-MON; -.
DR   BRENDA; 2.6.1.1; 399.
DR   BRENDA; 2.6.1.78; 399.
DR   BRENDA; 2.6.1.79; 399.
DR   SABIO-RK; Q9SIE1; -.
DR   UniPathway; UPA00121; UER00342.
DR   UniPathway; UPA00121; UER00343.
DR   PRO; PR:Q9SIE1; -.
DR   Proteomes; UP000006548; Chromosome 2.
DR   ExpressionAtlas; Q9SIE1; baseline and differential.
DR   Genevisible; Q9SIE1; AT.
DR   GO; GO:0009507; C:chloroplast; HDA:TAIR.
DR   GO; GO:0009570; C:chloroplast stroma; HDA:TAIR.
DR   GO; GO:0033853; F:aspartate-prephenate aminotransferase activity; IDA:UniProtKB.
DR   GO; GO:0033854; F:glutamate-prephenate aminotransferase activity; IDA:UniProtKB.
DR   GO; GO:0004069; F:L-aspartate:2-oxoglutarate aminotransferase activity; IDA:UniProtKB.
DR   GO; GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro.
DR   GO; GO:0008483; F:transaminase activity; IBA:GO_Central.
DR   GO; GO:0009095; P:aromatic amino acid family biosynthetic process, prephenate pathway; IDA:UniProtKB.
DR   GO; GO:0006520; P:cellular amino acid metabolic process; IBA:GO_Central.
DR   GO; GO:0009793; P:embryo development ending in seed dormancy; IMP:TAIR.
DR   GO; GO:0009094; P:L-phenylalanine biosynthetic process; IEA:UniProtKB-UniPathway.
DR   Gene3D; 3.40.640.10; -; 1.
DR   Gene3D; 3.90.1150.10; -; 1.
DR   InterPro; IPR004839; Aminotransferase_I/II.
DR   InterPro; IPR004838; NHTrfase_class1_PyrdxlP-BS.
DR   InterPro; IPR015424; PyrdxlP-dep_Trfase.
DR   InterPro; IPR015421; PyrdxlP-dep_Trfase_major.
DR   InterPro; IPR015422; PyrdxlP-dep_Trfase_small.
DR   Pfam; PF00155; Aminotran_1_2; 1.
DR   SUPFAM; SSF53383; SSF53383; 1.
DR   PROSITE; PS00105; AA_TRANSFER_CLASS_1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Amino-acid biosynthesis;
KW   Aminotransferase; Chloroplast; Plastid; Pyridoxal phosphate;
KW   Reference proteome; Transferase; Transit peptide.
FT   TRANSIT         1..55
FT                   /note="Chloroplast"
FT                   /evidence="ECO:0000305"
FT   CHAIN           56..475
FT                   /note="Bifunctional aspartate aminotransferase and
FT                   glutamate/aspartate-prephenate aminotransferase"
FT                   /id="PRO_0000401475"
FT   BINDING         107
FT                   /ligand="L-aspartate"
FT                   /ligand_id="ChEBI:CHEBI:29991"
FT                   /evidence="ECO:0000250"
FT   BINDING         193
FT                   /ligand="L-aspartate"
FT                   /ligand_id="ChEBI:CHEBI:29991"
FT                   /evidence="ECO:0000250"
FT   BINDING         243
FT                   /ligand="L-aspartate"
FT                   /ligand_id="ChEBI:CHEBI:29991"
FT                   /evidence="ECO:0000250"
FT   BINDING         445
FT                   /ligand="L-aspartate"
FT                   /ligand_id="ChEBI:CHEBI:29991"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         306
FT                   /note="N6-(pyridoxal phosphate)lysine"
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         1..47
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14993207"
FT                   /id="VSP_040191"
FT   CONFLICT        80
FT                   /note="K -> R (in Ref. 6; BX820081)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        87
FT                   /note="I -> M (in Ref. 6; BX820081)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        230
FT                   /note="T -> S (in Ref. 6; BX820081)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        290
FT                   /note="S -> P (in Ref. 6; BX820081)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        305
FT                   /note="S -> L (in Ref. 6; BX820081)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        331
FT                   /note="L -> S (in Ref. 6; BX820081)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        374
FT                   /note="F -> L (in Ref. 6; BX820081)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        394
FT                   /note="F -> L (in Ref. 6; BX820081)"
FT                   /evidence="ECO:0000305"
FT   HELIX           74..78
FT                   /evidence="ECO:0007829|PDB:5WMK"
FT   HELIX           83..96
FT                   /evidence="ECO:0007829|PDB:5WMK"
FT   HELIX           115..126
FT                   /evidence="ECO:0007829|PDB:5WMK"
FT   HELIX           139..153
FT                   /evidence="ECO:0007829|PDB:5WMK"
FT   HELIX           159..161
FT                   /evidence="ECO:0007829|PDB:5WMK"
FT   STRAND          162..167
FT                   /evidence="ECO:0007829|PDB:5WMK"
FT   HELIX           168..179
FT                   /evidence="ECO:0007829|PDB:5WMK"
FT   STRAND          185..191
FT                   /evidence="ECO:0007829|PDB:5WMK"
FT   HELIX           196..202
FT                   /evidence="ECO:0007829|PDB:5WMK"
FT   STRAND          206..211
FT                   /evidence="ECO:0007829|PDB:5WMK"
FT   HELIX           214..216
FT                   /evidence="ECO:0007829|PDB:5WMK"
FT   HELIX           222..228
FT                   /evidence="ECO:0007829|PDB:5WMK"
FT   STRAND          233..241
FT                   /evidence="ECO:0007829|PDB:5WMK"
FT   TURN            243..245
FT                   /evidence="ECO:0007829|PDB:5WMK"
FT   HELIX           251..262
FT                   /evidence="ECO:0007829|PDB:5WMK"
FT   STRAND          268..272
FT                   /evidence="ECO:0007829|PDB:5WMK"
FT   TURN            274..277
FT                   /evidence="ECO:0007829|PDB:5WMK"
FT   HELIX           288..290
FT                   /evidence="ECO:0007829|PDB:5WMK"
FT   TURN            292..294
FT                   /evidence="ECO:0007829|PDB:5WMK"
FT   HELIX           295..297
FT                   /evidence="ECO:0007829|PDB:5WMK"
FT   STRAND          298..304
FT                   /evidence="ECO:0007829|PDB:5WMK"
FT   TURN            305..309
FT                   /evidence="ECO:0007829|PDB:5WMK"
FT   HELIX           311..313
FT                   /evidence="ECO:0007829|PDB:5WMK"
FT   STRAND          316..319
FT                   /evidence="ECO:0007829|PDB:5WMK"
FT   HELIX           322..335
FT                   /evidence="ECO:0007829|PDB:5WMK"
FT   HELIX           341..351
FT                   /evidence="ECO:0007829|PDB:5WMK"
FT   HELIX           355..357
FT                   /evidence="ECO:0007829|PDB:5WMK"
FT   HELIX           358..380
FT                   /evidence="ECO:0007829|PDB:5WMK"
FT   STRAND          391..399
FT                   /evidence="ECO:0007829|PDB:5WMK"
FT   HELIX           401..403
FT                   /evidence="ECO:0007829|PDB:5WMK"
FT   STRAND          406..408
FT                   /evidence="ECO:0007829|PDB:5WMK"
FT   TURN            409..411
FT                   /evidence="ECO:0007829|PDB:5WMK"
FT   STRAND          412..414
FT                   /evidence="ECO:0007829|PDB:5WMK"
FT   HELIX           417..428
FT                   /evidence="ECO:0007829|PDB:5WMK"
FT   HELIX           435..438
FT                   /evidence="ECO:0007829|PDB:5WMK"
FT   STRAND          443..447
FT                   /evidence="ECO:0007829|PDB:5WMK"
FT   HELIX           452..466
FT                   /evidence="ECO:0007829|PDB:5WMK"
FT   HELIX           467..469
FT                   /evidence="ECO:0007829|PDB:6F5V"
SQ   SEQUENCE   475 AA;  51000 MW;  5F17130EE2533B38 CRC64;
     MASQSSVAVI SSAAARGESF PDSKKPIGSV RFQQPLRLSF SYCKSGNMSS RICAMAKPND
     AETLSSSVDM SLSPRVQSLK PSKTMVITDL AATLVQSGVP VIRLAAGEPD FDTPKVVAEA
     GINAIREGFT RYTLNAGITE LREAICRKLK EENGLSYAPD QILVSNGAKQ SLLQAVLAVC
     SPGDEVIIPA PYWVSYTEQA RLADATPVVI PTKISNNFLL DPKDLESKLT EKSRLLILCS
     PSNPTGSVYP KSLLEEIARI IAKHPRLLVL SDEIYEHIIY APATHTSFAS LPDMYERTLT
     VNGFSKAFAM TGWRLGYLAG PKHIVAACSK LQGQVSSGAS SIAQKAGVAA LGLGKAGGET
     VAEMVKAYRE RRDFLVKSLG DIKGVKISEP QGAFYLFIDF SAYYGSEAEG FGLINDSSSL
     ALYFLDKFQV AMVPGDAFGD DSCIRISYAT SLDVLQAAVE KIRKALEPLR ATVSV
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024